Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Omniactive Health Technologies Limited currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The portfolio involves 1 distinct examiner, Sophia P Hirakis, and 1 distinct art unit. Sophia P Hirakis is the busiest examiner, holding 1 pending office action. The presence of only 1 pending action indicates a very focused area of current prosecution. This concentration suggests a specific technological or legal focus for the company's current biotechnology applications.
The involvement of 1 distinct examiner, Sophia P Hirakis, and 1 distinct art unit suggests that the company's current intellectual property efforts are highly specialized. Because the 1 pending office action is the only active matter, the examiner's specific procedural habits will be the primary factor in the case's progression. This centralized structure within the Biotechnology & Pharmaceuticals sector allows for a streamlined and predictable prosecution experience. Practitioners can focus their resources on navigating the requirements of a single examiner and art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HIRAKIS, SOPHIA P | 1 | 56.1% | +73.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17762727 | NUTRITIONAL COMPOSITION FOR VISUAL FUNCTION | HIRAKIS, SOPHIA P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17762727 | NUTRITIONAL COMPOSITION FOR VISUAL FUNCTION | HIRAKIS, SOPHIA P | — |
| Art Unit | Apps |
|---|---|
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17762727 | NUTRITIONAL COMPOSITION FOR VISUAL FUNCTION | HIRAKIS, SOPHIA P | 1623 | §101§103 | Non-Final OA | — | Pending | Mar 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial